|Articles|May 21, 2019
I-ACT for Children Selects Advarra as Central IRB
Advertisement
Advarra has announced that it has been selected by the Institute for Advanced Clinical Trials for Children to provide central institutional review board services to the organization’s pediatric clinical trial site network. I-ACT for Children currently includes 44 U.S. pediatric research sites.
For further details, click
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Clinical Trials in 2026: Platformization, AI Fluency, and the Redrawing of the Value Chain
2
Breaking Out of AI Pilot Mode in Clinical Development
3
ACT Brief: Community Sites Compete on Readiness, COA Licensing Bottlenecks Slow Start-Up, and AI’s Foundations in Pharmacovigilance
4
ACT Brief: Community Sites Prove Readiness, Platformization Reshapes Clinical Ops, and AI Targets Precision Care at JPM
5